SAN DIEGO and SYDNEY — BioNano Genomics announced today the Garvan Institute of Medical Research has elected to incorporate the Irys technology into their disease research programs, with particular emphasis on improving understanding of prostate cancer. With their purchase of an Irys System, Garvan becomes the first Early Access user of the technology in Australia. […]
SANFORD, Maine — HypoxyCOOLTM, the new media conditioning system from Baker Ruskinn, accelerates the reduction of oxygen concentration in tissue/cell culture media to user-defined values by as much as two days. The system is the first commercialized solution for precisely controlling oxygen levels in liquid media used in stem cell expansion or any tissue culture […]
MOUNTAIN VIEW, Calif. — DNAnexus, a pioneer in cloud-based solutions for large-scale DNA data management and analysis, today announced a collaboration with Stanford University that has resulted in a new 1000 Genomes Project data set of genetic variation. Through this collaboration, scientists have analyzed and identified genetic variants in more than 80 terabytes (TB) of […]
Manassas, VA – ATCC, the premier global biological materials resource and standards organization, and Evercyte GmbH, a proven developer of immortalized human cells, have entered into a strategic partnership to develop and distribute immortalized cell lines that retain key performance characteristics of primary cells. Immortalized primary cell lines enable scientists to have a sufficient supply […]
OXFORD, England — Zyoxel, the world’s leading expert for advanced in vitro 3D liver models for drug discovery and drug testing, has announced preliminary results from a testing by Sanofi on Zyoxel’s LiverChip™ platform for drug metabolism and pharmacokinetic (DMPK) studies. Sanofi employed a variety of morphological, genetic and functional analyses to fully characterise the […]
Minneapolis, MN — ImmunoChemistry Technologies (ICT), a Minnesota-based biotechnology company that supplies unique biochemical laboratory reagents and assay tests to medical researchers, has changed ownership. Now majority women-owned, ICT develops new products to help researchers discover new treatments and drugs for cancer and other diseases affecting both animals and humans. The privately held company is […]
Otsu/Shiga Japan – Takara Bio Inc. announced today the launch of several new research reagents relating to adeno-associate virus (AAV) vectors for gene transduction that will become available for sale on December 16, 2013 through Takara Bio’s sales network. The most important feature of the AAV vectors that attracts gene therapy researchers is that the […]
FORT COLLINS, Colo. — Ventria Bioscience today announced that Margaret B. Glick, Ph.D., CPA has been appointed as the company’s new vice president of finance. Dr. Glick will oversee all financial and related administrative functions for the company. “Maggie comes to Ventria Bioscience with expertise in private and public corporate finance as well as organizational […]
ST. LOUIS – Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine, announced the expansion of its Cancer Genome Analysis (CGA) Suite to include additional tools for next-generation sequencing (NGS) analysis from the Broad Institute. The first addition to the suite is a method for estimating contamination levels in cancer […]
BILLERICA, Mass –– RainDance Technologies, Inc., a genomics tools company enabling development of ultra-sensitive and non-invasive methods for early detection of cancer and inherited diseases, today announced that Alfred G. (Alf) Merriweather has joined the company as Chief Financial Officer. Merriweather brings more than 25 years of executive level experience in private and public company […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
